名稱 | ESR1 p.Y537S Reference Standard |
型號(hào) | CBP10603 |
報(bào)價(jià) | ![]() |
特點(diǎn) | ESR1 p.Y537S Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 購(gòu)買(mǎi)細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn):ADORA2B(腺苷A2B受體)
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 探討腫瘤細(xì)胞的“冷與熱”之分
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- NCRI:新型檢測(cè)技術(shù)或能提前8年診斷出食管癌
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10603ESR1 p.Y537S Reference Standard

- 詳細(xì)內(nèi)容
CBP10603 | |
Format | Genomic DNA |
Description | ESR1, estrogen receptor alpha, modulates response to estrogen and is used as a marker to predict response to endocrine therapy in breast cancer patients. ESR1 fusions are recurrent in breast cancer, and mutations in ESR1 have been associated with decreased response to endocrine therapy in breast cancer. |
Technical Data | |
DNA Change | c.1610A>C |
AA Change | p.Y537S |
Mutation type | N/A |
Zygosity | N/A |
Allelic Frequency | N/A |
Transcript | N/A |
Cosmic ID | COSM1074639 |
Chr position(GRCh37) | N/A |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |